Semble AI has closed a £30 million Series C funding round, led by Revaia and Partech, with participation from existing investors Mercia Ventures and Octopus Ventures. This significant follow-on round will fuel the expansion of Semble's clinical platform, which is designed to improve care coordination for outpatient providers across Europe. The company, recognized as one of Europe's fastest-growing clinical platforms, aims to further enhance its patient journey management capabilities.
